Results 41 to 50 of about 3,173,890 (267)

The Use of Primary Care Electronic Health Records for Research: Lipid Medications and Mortality in Elderly Patients

open access: yesPharmacy, 2019
General practice electronic health record (EHR) data have significant potential for clinical research. This study demonstrates the feasibility of utilising longitudinal EHR data analysis to address clinically relevant outcomes and uses the relationship ...
Adam J. Hodgkins   +3 more
doaj   +1 more source

The hypolipidemic effect of Portulaca oleracea L. stem on hyperlipidemic Wister Albino rats [PDF]

open access: yes, 2016
Portulaca oleracea has been listed in the World Health Organization as one of the most used medicinal plants. Portulaca oleracea stems (POS) acts about 75% from weight of plant. The production of stems was the most economic between other organs.
El-Newary, Samah Ali
core   +1 more source

Age may determine the effect of hypolipidemic agents on plasma adipokine levels in patients with elevated low-density lipoprotein cholesterol levels.

open access: yesEndokrynologia Polska, 2015
INTRODUCTION Lipid-lowering agents affect adipose tissue function. No study has investigated the role of age in the effects of hypolipidaemic agents on plasma adipokines.
R. Krysiak   +3 more
semanticscholar   +1 more source

Prosopis alba seed flour improves vascular function in a rabbit model of high fat diet-induced metabolic syndrome [PDF]

open access: yes, 2019
Aims: Prosopis alba flour is a natural source of nutrient and phytochemicals with potential effects on cardiovascular risk factors. The aim of this work was to examine the effects of dietary supplementation with Prosopis alba seed flour (Pr-Feed) on a ...
Alarcón, Gabriela del Jesús   +4 more
core   +1 more source

Study on the influence of 7-β-hydroxy-γ-aryloxypropylxanthinyl-8-thioalkanic acid derivatives on the lipid metabolism in experiment

open access: yesZaporožskij Medicinskij Žurnal, 2021
Statin side effects are not a rare occurrence, in particular dyspeptic disorders, insomnia, headache, skin erythema, rash are often noted. All of this determines scientists to find new effective and low-toxic hypolipidemic agents.
I. M. Bilai   +2 more
doaj   +1 more source

PLACEBO-CONTROLLED STUDY ON COMPARISON OF TWO HERBAL HYPOLIPIDEMIC AGENTS

open access: yes, 2016
Introduction: Hyperlipidemia, either primary or secondary causes atherogenetic abnormalities leading to coronary artery disease, cardiac arrest and arrhythmias.
K. Niaz   +4 more
semanticscholar   +1 more source

Lipid-lowering drug prescriptions in a group of Colombian patients

open access: yesBiomédica: revista del Instituto Nacional de Salud, 2019
Introduction. Lipid-lowering drugs, especially statins, have shown great relevance in preventing and treating cardiovascular diseases. Objective. To determine the prescription patterns of lipid-lowering drugs and the variables associated with their use ...
Andres Gaviria-Mendoza   +2 more
doaj   +1 more source

MODELING OF MICE AS TEST ANIMALS FOR A PRECLINICAL STUDY OF HYPOLIPIDEMIC AGENTS

open access: yesJurnal Farmasi Sains dan Praktis, 2023
Animal models suitable for preclinical research are necessary for the discovery of hypolipidemic agents. Various publications have presented alternative dyslipidemia animal models, but identifying a feasible and stable method would serve as a solid ...
Setiyo Budi Santoso   +2 more
doaj   +1 more source

Comparative analysis of the use of lipid modifying agents in the Republic of Serbia and Nordic countries in the period 2015-2017 [PDF]

open access: yesHospital Pharmacology, 2020
Introduction: Cardiovascular diseases are the leading cause of death both in Serbia and in the rest of the world. It has been shown that as many as 80% of them are preventable.
Martić Nikola B.   +9 more
doaj  

Bempedoic acid and its role in contemporary management of hyperlipidemia in atherosclerosis

open access: yesAnnals of Medicine, 2022
Atherosclerotic heart disease is the leading cause of mortality and morbidity in the USA. Low density lipoprotein (LDL) has been the target for many hypolipidemic agents to modify atherosclerotic risk.
Ramyashree Tummala   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy